Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


GREY:CLAZF - Post by User

Post by Captainblkon Feb 06, 2021 7:50pm
332 Views
Post# 32494425

This gives me less and less and less confidence

This gives me less and less and less confidenceI am becoming less and less confident about this all the more I start to dig.
  1. outside of Robert, the whole team is a copy and paste from the Salzman Team site:Team - Claritas Pharmaceuticals
  2. Team - Salzman (salzmangrp.com) photo and blog pulled right from the page
  3. if you go to the History tab on Salzman you can see a series of companies that they have founded.History - Salzman (salzmangrp.com)  googling each one leads you on some interesting paths. some are around, some seem like they've been deadended like what appears is about to happen to KLY:
  • inotek is still around, and trading; radikals last press release was 2016;
  • Orphan technologies was sold off last year for an appearant 500 million- which begs the question why KLY was to acquire Salzman and not the other way around.(thats the same question I'd have right now with this new company) .
  • beetlebung is the earliest mention of kaly, where they seem to have started this shell game by licencing some spinal cord therapy to KLY- that must have been before I got in during the Canniboid/GVHD work I was investing in. 
  • the last point in the history thread mentions Herring Creek Pharmaceuticals, which was divested off to a Steady State Inc- both these companies seem to have little to no online existance from a cursory search. thats a bit of concern for me TBH. 
this mild deep dive is causing me some concern, as it looks to be a shell game of companies with non tangible products that are more loose patents than they are concrete medical break throughs. I would love to see some counter arguements, otherwise its a wait and see what NR's come out. 



<< Previous
Bullboard Posts
Next >>